Has Devraj Sukul, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,128 in general payments to Devraj Sukul, MD across 197 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Devraj Sukul, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Devraj Sukul, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Devraj Sukul, MD

Interventional Cardiology · Grand Rapids, MINPI 1205120391

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 57.9% of the total.

$13,128in general payments, 2019–2025

Across 197 payments — averaging $66.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Abbott$2K
Edwards Lifesciences$1K
Philips North America LLC$828
Shockwave Medical, Inc$422
Boston Scientific$320
plus $362 from 6 others

$60,119in research payments, 2019–2025

Across 11 payments — averaging $5465.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$60K

What the payments were for

Travel & lodging$5,68843%
Food & beverage$7,39956%
Education$420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	139	$7,601
Abbott	17	$2,127
Edwards Lifesciences	16	$1,468
Philips North America LLC	9	$828
Shockwave Medical, Inc	5	$422
Boston Scientific	3	$320
Cardiovascular Systems Inc.	1	$156
Cardinal Health 200 LLC	2	$92
Spectrawave, Inc	2	$58
Teleflex LLC	1	$19
E.r. Squibb & Sons, L.L.C.	1	$19
Biosense Webster, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$3,139
TRICLIP$1,468
CoreValve Evolut$1,104
PASCAL$877
(9520) IGT Devices Undivided$379
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$342
(9525) Intracardiac Und$241
NAVITOR$215
VersaCross Access Solution$161
Diamondback Peripheral$156
Diamondback Coronary$156
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$134
MitraClip$108
GENERAL VASCULAR ACCESS$103

How this compares

$13,128 in reported general payments places this provider in the 70th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan →

Medicare billing

Part B allowed, 2024

$55,684

Medicare patients

128

Services billed

350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	24	$36,656
Atorvastatin Calcium	84	$1,279
Metoprolol Succinate	57	$925
ClopidogrelClopidogrel Bisulfate	44	$701
Rosuvastatin Calcium	48	$640
Bisoprolol Fumarate	14	$534
Amlodipine Besylate	51	$512
Isosorbide Mononitrate ErIsosorbide Mononitrate	38	$506
Ezetimibe	19	$477
Carvedilol	18	$251
Lisinopril	29	$237
Omeprazole	11	$71
Furosemide	15	$57

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Grand Rapids

Duane BerkompasGrand Rapids$159K
David WohnsGrand Rapids$129K
William MerhiGrand Rapids$114K
Timothy JosephGrand Rapids$17K
Cody CarterGrand Rapids$12K
Amir KakiDetroit$1.8M
Tamam MohamadDetroit$960K
Paul GrossmanAnn Arbor$630K
Jason RicciPetoskey$594K
Tim FischellKalamazoo$468K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →